Salesforce Inc – Further margin expansion March 7, 2024 455

PSR Recommendation: ACCUMULATE Status: Maintained
Target Price: 323.00
  • FY24 revenue/adj. PATMI met our expectations at 100% of our forecasts. 4Q24 adj. PATMI jumped 36% YoY to US$2.3bn driven by higher operating leverage.
  • For FY25e, Salesforce expects revenue to grow 9% YoY to US$37.9bn driven by strong momentum in its MuleSoft and Tableau offerings. Adj. EPS expected to grow 18% YoY to US$9.7 led by cost-containment efforts. Salesforce declared its first-ever quarterly dividend of US$0.40 per share and increased its share buyback program by US$10bn.
  • We maintain ACCUMULATE with a raised DCF target price of US$323.00 (prev. US$270.00) as we roll over an additional year of valuations. Our WACC/g assumptions remain unchanged at 7%/4%, respectively. We nudge lower our FY25e revenue estimates by 1% to account for FX headwinds and declining professional services revenue, while we increase our adj. PATMI by 3% due to lower expenses. Catalysts include continued margin expansion, focus on maximising shareholder returns, and resilient demand for its Customer 360 cloud offerings as companies look to form a more holistic view of their customer data to provide better customer experiences.

 

 

The Positives

+ Multiproduct deals continued to drive growth. 4Q24 revenue grew 11% YoY (10% in constant currency) to US$9.3bn, 1% above the top end of company guidance, driven by higher subscription sales. On a product level, Sales/Service Cloud demand remained resilient with revenues growing by 10%/12% YoY to US$2.0bn and US$2.2bn, respectively. Integration and Analytics revenue delivered robust growth of 21% YoY to US$1.6bn, driven by strength in MuleSoft and Tableau offerings. Management highlighted that the number of large enterprise deals (those greater than US$10mn) grew by 78% YoY, with over 86,000 multiproduct deals. This was mainly driven by continuous product enhancements and its pricing and product bundling strategies. For instance, Salesforce Starter suite bundles Sales, Service, and Marketing tools together in one platform leading to significant surge in average sales price.

 

+ Margins continue to improve. Gross and operating margins expanded by 200bps and 1,300bps YoY, respectively. Operating income spiked more than 4-fold to US$1.6bn. The margin improvement was mainly due to top-line upside and higher operating leverage (OPEX down 7% YoY) from prudent headcount control and lower sales-related costs. In FY23, Salesforce cut jobs by 10% and closed some offices.

 

The Negative

– FY25e revenue guidance below our forecast. For FY25e, Salesforce expects total revenue to grow 9% YoY to US$37.9bn at the midpoint, which was below our estimate of US$38.6bn. This was because the company expects foreign exchange currency rates to negatively impact its revenues by US$100mn. In addition, Salesforce’s professional services business (revenue down 9% YoY in 4Q24) is expected to continue to be impacted due to the compression of larger transformation deals.

Important Information

This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.

By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.

The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.

Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.

This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.

Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.

Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.

Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.

To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.

The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.

This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.

This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.

IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE

Where the report contains research analyses or reports from a foreign research house, please note:

  1. recipients of the analyses or reports are to contact Phillip Securities Research (and not the relevant foreign research house) in Singapore at 250 North Bridge Road, #06-00 Raffles City Tower, Singapore 179101, telephone number +65 6533 6001, in respect of any matters arising from, or in connection with, the analyses or reports; and
  2. to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, Phillip Securities Research accepts legal responsibility for the contents of the analyses or reports.
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Get access to all the latest market news, reports, technical analysis
by signing up for a free account today!